ArticlebioRxiv : the preprint server for biology2024

Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma.

Qiyan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.